Gillian Harcourt

2.5k total citations
43 papers, 2.0k citations indexed

About

Gillian Harcourt is a scholar working on Immunology, Hepatology and Neurology. According to data from OpenAlex, Gillian Harcourt has authored 43 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 16 papers in Hepatology and 14 papers in Neurology. Recurrent topics in Gillian Harcourt's work include Hepatitis C virus research (16 papers), Immune Cell Function and Interaction (14 papers) and Myasthenia Gravis and Thymoma (13 papers). Gillian Harcourt is often cited by papers focused on Hepatitis C virus research (16 papers), Immune Cell Function and Interaction (14 papers) and Myasthenia Gravis and Thymoma (13 papers). Gillian Harcourt collaborates with scholars based in United Kingdom, United States and India. Gillian Harcourt's co-authors include Paul Klenerman, Michaela Lucas, John Newsom–Davis, Norbert Sommer, Nick Willcox, Eleanor Barnes, Cheryl L. Day, Nicholas Willcox, Nasser Semmo and Nilufer P. Seth and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Gillian Harcourt

43 papers receiving 2.0k citations

Peers

Gillian Harcourt
Anita Lewis-Antes United States
David D. Eckels United States
SangKon Oh United States
Gaia Nebbia United Kingdom
Gillian Harcourt
Citations per year, relative to Gillian Harcourt Gillian Harcourt (= 1×) peers Stefania Varchetta

Countries citing papers authored by Gillian Harcourt

Since Specialization
Citations

This map shows the geographic impact of Gillian Harcourt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian Harcourt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian Harcourt more than expected).

Fields of papers citing papers by Gillian Harcourt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillian Harcourt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian Harcourt. The network helps show where Gillian Harcourt may publish in the future.

Co-authorship network of co-authors of Gillian Harcourt

This figure shows the co-authorship network connecting the top 25 collaborators of Gillian Harcourt. A scholar is included among the top collaborators of Gillian Harcourt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillian Harcourt. Gillian Harcourt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fleming, Vicki M., Gillian Harcourt, Eleanor Barnes, & Paul Klenerman. (2010). Virological footprint of CD4+ T-cell responses during chronic hepatitis C virus infection. Journal of General Virology. 91(6). 1396–1406. 26 indexed citations
3.
Semmo, Nasser, Cheryl L. Day, Scott M. Ward, et al.. (2005). Preferential loss of IL‐2–secreting CD4+ T helper cells in chronic HCV infection†. Hepatology. 41(5). 1019–1028. 135 indexed citations
4.
Harcourt, Gillian, Michaela Lucas, Isabelle Sheridan, et al.. (2004). Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA‐DR11 restricted epitopes. Journal of Viral Hepatitis. 11(4). 324–331. 18 indexed citations
5.
Day, Cheryl L., Nilufer P. Seth, Michaela Lucas, et al.. (2003). Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. Journal of Clinical Investigation. 112(6). 831–842. 222 indexed citations
6.
Καντζάνου, Μαρία, Michaela Lucas, Eleanor Barnes, et al.. (2003). Viral escape and T cell exhaustion in hepatitis C virus infection analysed using Class I peptide tetramers. Immunology Letters. 85(2). 165–171. 49 indexed citations
7.
Barnes, Eleanor, Gillian Harcourt, David Brown, et al.. (2002). The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection. Hepatology. 36(3). 743–754. 118 indexed citations
8.
Klenerman, Paul, Michaela Lucas, Eleanor Barnes, & Gillian Harcourt. (2002). Immunity to hepatitis C virus: stunned but not defeated. Microbes and Infection. 4(1). 57–65. 26 indexed citations
9.
Harcourt, Gillian, Sarah Garrard, Miles P. Davenport, Anne Edwards, & Rodney E. Phillips. (1998). HIV-1 Variation Diminishes CD4 T Lymphocyte Recognition. The Journal of Experimental Medicine. 188(10). 1785–1793. 54 indexed citations
10.
Sewell, Andrew K., Gillian Harcourt, Philip Goulder, David A. Price, & Rodney E. Phillips. (1997). Antagonism of cytotoxic T lymphocyte‐mediated lysis by natural HIV‐1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides. European Journal of Immunology. 27(9). 2323–2329. 60 indexed citations
11.
Savage, Caroline O.S., Gillian Harcourt, J Picard, et al.. (1995). Human vascular endothelial cells process and present autoantigen to human T cell lines. International Immunology. 7(3). 471–479. 56 indexed citations
12.
Gilhus, Nils Erik, et al.. (1995). Antigen presentation by thymoma epithelial cells from myasthenia gravis patients to potentially pathogenic T cells. Journal of Neuroimmunology. 56(1). 65–76. 37 indexed citations
13.
Willcox, Nicholas, Fulvio Baggi, David Beeson, et al.. (1993). Approaches for Studying the Pathogenic T Cells in Autoimmune Patientsa. Annals of the New York Academy of Sciences. 681(1). 219–237. 24 indexed citations
14.
Harcourt, Gillian, et al.. (1993). Differential Recognition by T Cells of the P3A+ and P3A Isoforms of the Human Acetylcholine Receptor Alpha‐Subunit. Annals of the New York Academy of Sciences. 681(1). 280–282. 3 indexed citations
15.
Sun, Jiabin, Gillian Harcourt, Zeng‐Yu Wang, et al.. (1992). T cell responses to human recombinant acetylcholine receptor‐α subunitin myasthenia gravis and controls. European Journal of Immunology. 22(6). 1553–1559. 25 indexed citations
16.
Newsom–Davis, John, Gillian Harcourt, Norbert Sommer, et al.. (1989). T-cell reactivity in myasthenia gravis. Journal of Autoimmunity. 2. 101–108. 56 indexed citations
17.
Harcourt, Gillian, et al.. (1988). Blood and Thymic Lymphocyte Responses to Peptide Sequences of the Acetylcholine Receptor in Myasthenia Gravis. Annals of the New York Academy of Sciences. 540(1). 354–356. 1 indexed citations
18.
Harcourt, Gillian, Norbert Sommer, Jonathan B. Rothbard, H. N. A. Willcox, & John Newsom–Davis. (1988). A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis.. Journal of Clinical Investigation. 82(4). 1295–1300. 70 indexed citations
19.
Newsom–Davis, John, Nick Willcox, Myriam Schluep, et al.. (1987). Immunological Heterogeneity and Cellular Mechanisms in Myasthenia Gravisa. Annals of the New York Academy of Sciences. 505(1). 12–26. 53 indexed citations
20.
Harcourt, Gillian, et al.. (1987). Mapping the autoimmunizing epitopes on acetylcholine receptors. Immunology Today. 8(11). 319–321. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026